The strong expression of Wnt5a at the leading edge, as well as in tumor-surrounding stroma cells, in conjunction with the polarised expression of Fzd3 within the tumor mass suggest that Wnt5a gradients project into the tumor to enhance motility in distinct subpopulations. The gene discussed is WNT5A; the disease is neoplasm.